Concepedia
Statistics
Publications
26
Citations
2.5K
H-Index
21
Active since
1978
Affiliations
Janssen (United States)(Current)
Janssen Scientific Affairs (United States)
University of Texas Health Science Center at Dallas
Johnson & Johnson (United States)
Experimental Pathology Laboratories
J. Thomas Haskins is an author at Janssen (United States) specializing in pharmacology, psychopharmacology, and medicine.
Publications per year
1978–2011
Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative
Eric A. Muth, J. Thomas Haskins, John A. Moyer et al. · Biochemical Pharmacology · 1986 · 374 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +16
Efficacy, Safety, and Tolerability of Venlafaxine Extended Release and Buspirone in Outpatients With Generalized Anxiety Disorder
Jonathan R. T. Davidson, Robert L. DuPont, J. Thomas Haskins · The Journal of Clinical Psychiatry · 1999 · 304 citations
Medicine, Pharmacology, Psychiatry +17
Efficacy of Venlafaxine Extended-Release Capsules in Nondepressed Outpatients With Generalized Anxiety Disorder
Alan J. Gelenberg, R. Bruce Lydiard, Richard L. Rudolph et al. · JAMA · 2000 · 295 citations
Medicine, Pharmacology, Psychiatry +14
Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder
Karl Rickels, Mark H. Pollack, David V. Sheehan et al. · American Journal of Psychiatry · 2000 · 254 citations
Medicine, Pharmacotherapy, Psychiatry +17
WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors
Allan Fletcher, David J. Bill, Sarah J. Bill et al. · European Journal of Pharmacology · 1993 · 221 citations
Medicine, Neuroscience, Pharmacology +14
1–5 of 26